Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Accuray Inc (ARAY)

Accuray Inc (ARAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 258,831
  • Shares Outstanding, K 99,169
  • Annual Sales, $ 447,610 K
  • Annual Income, $ -9,280 K
  • 60-Month Beta 1.44
  • Price/Sales 0.57
  • Price/Cash Flow N/A
  • Price/Book 5.28
Trade ARAY with:

Options Overview Details

View History
  • Implied Volatility 85.78% ( +40.00%)
  • Historical Volatility 56.07%
  • IV Percentile 91%
  • IV Rank 17.54%
  • IV High 403.95% on 08/10/23
  • IV Low 18.10% on 11/30/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 226
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 5,536
  • Open Int (30-Day) 11,124

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.00
  • Number of Estimates 3
  • High Estimate 0.01
  • Low Estimate -0.01
  • Prior Year 0.01
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.48 +3.42%
on 03/06/24
2.95 -12.88%
on 03/07/24
-0.21 (-7.55%)
since 02/16/24
3-Month
2.36 +8.90%
on 02/06/24
3.05 -15.74%
on 12/27/23
-0.14 (-5.17%)
since 12/18/23
52-Week
2.36 +8.90%
on 02/06/24
4.30 -40.22%
on 07/31/23
-0.23 (-8.21%)
since 03/17/23

Most Recent Stories

More News
Accuray: Fiscal Q2 Earnings Snapshot

Accuray: Fiscal Q2 Earnings Snapshot

ARAY : 2.57 (-1.53%)
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 65.85 (-0.69%)
ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
DSNKY : 32.9600 (+2.01%)
GILD : 73.26 (-0.58%)
ARAY : 2.57 (-1.53%)
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 65.85 (-0.69%)
ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
DSNKY : 32.9600 (+2.01%)
GILD : 73.26 (-0.58%)
ARAY : 2.57 (-1.53%)
Accuray: Fiscal Q1 Earnings Snapshot

Accuray: Fiscal Q1 Earnings Snapshot

ARAY : 2.57 (-1.53%)
Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy...

ARAY : 2.57 (-1.53%)
Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenosâ„¢, for...

ARAY : 2.57 (-1.53%)
Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has opened the doors of its new global training facility, the Accuray...

ARAY : 2.57 (-1.53%)
Accuray to Host Investor Day at ASTRO on October 3, 2023

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3,...

ARAY : 2.57 (-1.53%)
Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration...

ARAY : 2.57 (-1.53%)
Accuray: Fiscal Q4 Earnings Snapshot

Accuray: Fiscal Q4 Earnings Snapshot

ARAY : 2.57 (-1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing...

See More

Key Turning Points

3rd Resistance Point 2.67
2nd Resistance Point 2.65
1st Resistance Point 2.61
Last Price 2.57
1st Support Level 2.55
2nd Support Level 2.53
3rd Support Level 2.49

See More

52-Week High 4.30
Fibonacci 61.8% 3.56
Fibonacci 50% 3.33
Fibonacci 38.2% 3.10
Last Price 2.57
52-Week Low 2.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar